- Report
- January 2024
- 156 Pages
United States
€3410EUR$3,800USD£2,935GBP
- Report
- January 2024
- 114 Pages
United States
€3140EUR$3,500USD£2,703GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €449EUR$500USD£386GBP
Pulmicort (budesonide) is a corticosteroid medication used to treat asthma and other respiratory diseases. It is available in both an inhaler and a nebulizer solution. Pulmicort works by reducing inflammation in the airways, which helps to reduce symptoms such as wheezing, coughing, and shortness of breath. It is often used in combination with other medications to treat more severe cases of asthma.
Pulmicort is part of a larger class of medications known as respiratory drugs. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Other types of respiratory drugs include bronchodilators, anti-inflammatory medications, and antibiotics.
Some companies that produce Pulmicort include AstraZeneca, Boehringer Ingelheim, and Teva Pharmaceuticals. Show Less Read more